The Effect of Adding Nalbuphine to Intrathecal Morphine on Analgesic Efficacy and Side Effects After Cesarean Section
Launched by ABDELRADY S IBRAHIM, MD · Mar 22, 2016
Trial Information
Current as of May 20, 2025
Completed
Keywords
ClinConnect Summary
The study will be performed in Assiut University Hospitals, after obtaining approval from the local ethics committee and written informed patient consent. All patients will have a peripheral IV cannula 18 G inserted; standard non-invasive monitors will be applied. All the patients will be preloaded with 10 ml/kg Ringer's lactate solution intravenous. Intrathecal block under strict aseptic conditions will be performed in sitting position at L3-4 or L4-5 inter-spinous space with 25G pencil-point spinal needle. All patients will receive intrathecal 10 mg of 0.5% hyperbaric bupivacaine.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female patients
- • age between 16 to 40 years
- • ASA physical status I - II
- Exclusion Criteria:
- • Infection at the site of injection.
- • Coagulopathy or other bleeding diathesis.
- • Preexisting neurologic deficits.
- • History of hypersensitivity to any of the given the drugs.
- • Inability to communicate with the investigator and the hospital staff.
- • History of chronic opioid us
About Abdelrady S Ibrahim, Md
Abdelrady S. Ibrahim, MD, is a distinguished clinical trial sponsor dedicated to advancing medical research and innovation. With extensive expertise in clinical methodologies and patient care, Dr. Ibrahim leads initiatives that focus on evaluating novel therapies and treatments across various medical disciplines. Committed to maintaining the highest ethical standards, he fosters collaboration among multidisciplinary teams to ensure rigorous study design and implementation. Under his guidance, the trials aim to enhance patient outcomes and contribute valuable insights to the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assiut, , Egypt
Patients applied
Trial Officials
Abdelrady S Ibrahim, MD
Principal Investigator
Assistant professor of anesthesia and intensive care
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials